[Federal Register Volume 86, Number 121 (Monday, June 28, 2021)]
[Notices]
[Page 34045]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13671]



[[Page 34045]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-846]


Bulk Manufacturer of Controlled Substances Application: Chemic 
Laboratories

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Chemic Laboratories, has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before August 27, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before August 27, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on April 30, 2021, Chemic Laboratories, 480 Neponset 
Street, Building 7, Canton, Massachusetts 02021-1971, applied to be 
registered as a bulk manufacturer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Psilocybin.............................     7437  I
Psilocyn...............................     7438  I
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances for research and development in preclinical 
studies for sale to its customers. No other activities for these drug 
codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-13671 Filed 6-25-21; 8:45 am]
BILLING CODE P